Help with menopause after cancer
Symptoms, diagnosis and specialist care
Menopause after cancer can be complex, both physically and emotionally.
For some people, menopause occurs earlier than expected as a result of cancer treatment. For others, menopausal symptoms may worsen or become more difficult to manage following a cancer diagnosis.
At Manchester Menopause Hive, we support people navigating menopause during and after cancer treatment, with careful, individualised assessment and evidence-based guidance. Our approach balances safety with quality of life, recognising that both are important.
Menopause after cancer: Key points
- Cancer treatment can trigger early, sudden, or more severe menopause, particularly after chemotherapy, ovarian suppression, or surgery
- Menopausal symptoms after cancer can be physically and emotionally challenging, and deserve specialist support
- There are effective non-hormonal treatment options for hot flushes, sleep disturbance, mood changes, and vaginal symptom
- After breast cancer, systemic HRT is not usually recommended as a first line treatment, especially in hormone-sensitive disease
- In rare, carefully selected situations, HRT may be discussed after breast cancer, following specialist assessment and shared decision-making
- Low-dose vaginal oestrogen can usually be considered for ongoing vaginal or urinary symptoms when non-hormonal options have not been effective
- Menopause care after cancer should always be individualised, evidence-based, and specialist-led
How cancer treatment can affect menopause
Cancer treatment can affect ovarian function and hormone levels in several ways, including:
- Chemotherapy or radiotherapy affecting the ovaries
- Surgical removal of the ovaries, with or without hysterectomy
- Medical ovarian suppression
- Hormone-blocking treatments used in hormone-sensitive cancers
When menopause occurs suddenly due to cancer treatment, symptoms are often more severe and harder to adapt to. Common symptoms include hot flushes, night sweats, sleep disturbance, mood changes, fatigue, joint pains, and vaginal or urinary symptoms.
Menopause after breast cancer
Menopause management after breast cancer often requires particular care, especially where the cancer was hormone receptor positive.
Common challenges
People commonly report:
- Severe hot flushes and night sweats
- Sleep disruption and fatigue
- Joint pain and stiffness
- Low mood or anxiety
- Vaginal dryness, pain during sex, or recurrent urinary symptoms
- Reduced libido and changes in body confidence
Non-hormonal treatment options after breast cancer
(Aligned with NICE and BMS guidance)
When systemic HRT is not suitable, there are a variety of non-hormonal options that can be effective.
Treatments for hot flushes and night sweats
Antidepressant medications (SSRIs and SNRIs)
Certain SSRIs and SNRIs can reduce the frequency and severity of hot flushes. Careful selection is required, particularly for people taking tamoxifen, due to potential drug interactions.
Gabapentin
Gabapentin may help reduce night sweats and improve sleep, especially when symptoms are worse overnight.
Clonidine
Clonidine may be considered in selected cases, although side effects can limit tolerability and so this is less often used
Oxybutynin
Oxybutynin (off licence) has evidence supporting its use in reducing hot flushes, including in people with a history of breast cancer, although side effects can be problematic.
Neurokinin 3 receptor antagonists
These newer treatments act on thermoregulation pathways in the brain rather than on hormones.
Fezolinetant
- Licensed in the UK for moderate to severe vasomotor symptoms
- Does not act on oestrogen receptors
- Requires liver function monitoring
- It may improve sleep for some women
- Currently only available privately.
Fezolinetant may be appropriate for some people after breast cancer following specialist assessment, although this is off licence.
Longer-term safety data, including use after hormone-sensitive cancers, is still emerging.
Elinzanetant
Elinzanetant is a neurokinin 1 and 3 receptor antagonist which works in a similar way to fezolinetant.
Unlike fezolinetant, Elinzanetant has undergone clinical trials in women following breast cancer, with positive results. Whilst it has been approved by the MHRA in the UK, it is not yet routinely available in UK practice, although hopefully it will be soon.
Sleep, mood, and fatigue
Sleep disturbance, low mood, and anxiety are common after breast cancer and may be worsened by menopausal symptoms.
Support may include:
- Non-hormonal medication where appropriate
- Psychological approaches such as cognitive behavioural therapy specifically for sleep (CBTi)
- Addressing contributing factors such as pain, anxiety, or treatment side effects
Lifestyle and behavioural approaches
NICE and BMS guidance highlight lifestyle measures as supportive strategies alongside medical treatment:
- Consistent sleep routines
- Gentle to moderate regular physical activity
- Identifying and reducing triggers for hot flushes where relevant
- Strength and weight-bearing exercise for bone health
- Stress management and emotional support
These approaches are supportive but should not replace medical treatment when symptoms are severe.
Complementary therapies
Acupuncture
Acupuncture may provide modest benefit for some people, particularly for hot flushes and sleep disturbance, although evidence is mixed
Caution is advised with supplements or products claiming to balance hormones. Some supplements are not recommended following breast cancer and therefore it is important to access specialist advice from your menopause specialist or breast care nurse.
What about vaginal and bladder symptoms after hormone sensitive cancers?
For people experiencing severe genitourinary symptoms of menopause, such as vaginal dryness, pain during sex, or recurrent urinary symptoms, these symptoms should not be ignored. They can significantly impact quality of life and treatment is often very effective.
- First line options include vaginal moisturisers and lubricants, using brands such as YES or Sutil which can help with comfort day to day.
- If these are not effective, low-dose vaginal oestrogen can often be used, in line with current evidence and BSSM guidance, although discussion with a specialist is important.
- Local vaginal oestrogen is not the same as systemic HRT and results in minimal systemic absorption.
- The exception to this is individuals using an aromatase-inhibitor medication such as letrozole or anastrazole, when decisions regarding vaginal oestrogen are more complex and may involve discussion with the oncology team
Can HRT ever be an option after breast cancer?
For most people with a history of breast cancer, particularly hormone receptor-positive breast cancer, systemic hormone replacement therapy (HRT) is not routinely recommended. This is because of concerns about the potential risk of cancer recurrence.
However, menopause care after breast cancer is not always straightforward, and in rare and carefully selected circumstances, the use of systemic HRT may be discussed.
When might this be considered?
Discussion about systemic HRT may occur when:
- Menopausal symptoms are severe, persistent, and significantly affecting quality of life
- Evidence-based non-hormonal treatment options have been tried and found to be ineffective or poorly tolerated
- The individual understands the known risks, uncertainties, and limitations of the available evidence
- The decision is made jointly, with input from menopause specialists and the oncology team
This is not a routine approach and would only be considered following a thorough, individualised risk-benefit assessment.
What does current guidance say?
- NICE and British Menopause Society guidance advises that systemic HRT should generally be avoided after breast cancer, particularly in hormone-sensitive disease
- However, this guidance also acknowledges that exceptional circumstances may arise where quality of life is severely affected and all other options have been exhausted
- In these situations, shared decision-making and specialist input are essential
There is limited high-quality evidence in this area, and uncertainty should always form part of the discussion.
Menopause after gynaecological cancers
Menopause after gynaecological cancer depends on the cancer type and treatment received, including cancers of the ovary, womb, cervix, vulva, or vagina.
Surgical menopause
Removal of the ovaries causes immediate menopause, regardless of age. Symptoms can be sudden and severe, particularly in younger people.
Is HRT ever an option?
For some gynaecological cancers, HRT may be considered safe and appropriate, particularly where the cancer was not hormone-sensitive. Decisions depend on the specific diagnosis, stage, treatment history, and individual risk profile, and are made with specialist input.
Bone and long-term health after cancer-related menopause
Early or treatment-induced menopause increases the risk of osteoporosis and cardiovascular disease.
We consider:
- Bone density assessment where appropriate
- Calcium and vitamin D advice
- Strength and weight-bearing exercise
- Cardiovascular and metabolic health
Emotional wellbeing after cancer and menopause
Menopause after cancer can carry a significant emotional burden. Feelings of loss, fear, grief, or disconnection from the body are common and valid, and deserve compassionate support.
Our approach at Manchester Menopause Hive
We offer:
- Unrushed specialist consultations where you can be listened to
- Individualised risk-benefit discussions
- Evidence-based care aligned with national guidance
- Collaboration with oncology teams where appropriate
- An understanding of the impact of menopausal symptoms on quality of life.
Key points
- Menopause after cancer is common and often complex
- Symptoms may be more severe after treatment-induced or surgical menopause
- Systemic HRT is usually avoided after breast cancer, but rare exceptions may be discussed
- Effective non-hormonal treatment options are available
- Care should always be individualised and specialist-led
MENOPAUSE AFTER CANCER SUPPORT
Book an appointment with one of our Menopause experts
Face-to-face and online appointments are available.
